Relationship between antithrombotic activities of fucans and their structure

Catherine Boisson‐Vidal, Frédéric Chaubet, Lionel Chevolot, Corinne Sinquin, Jocelyne Theveniaux, J. Millet, C. Sternberg, Barbara Mulloy, Anne Marie Fischer

Drug Development Research · 2000 · 54 citations · 28 references

Concepts

Abstract

Abstract A low molecular weight fucan fraction extracted from the brown seaweed Ascophyllum nodosum was previously shown to exhibit dose‐related venous antithrombotic activity with an ED 80 of about 20 mg/kg, 2 h after a single subcutaneous injection HCII (Colliec et al. [1991] Thromb Res 64:143–154; Mauray et al. [1995] Thromb Haemast 74:1280–1285). Its activity was comparable to that of a low molecular weight heparin (Dalteparin ® ). This fucan fraction is one of several, with a range of different structure parameters, prepared by degradation of the whole native fucan. These low molecular weight fractions were compared using a Wessler stasis thrombosis model in rabbits and by determination of their in vitro and ex vivo anticoagulant activities. Intravenous administrations of these fractions reduced thrombosis in a dose‐dependent manner. Partial removal of sulfate groups and/or partial degradation lead to a significant decrease in their anticoagulant and antithrombotic activities. The integrity of the regular pattern of sulphation of the fucoidan is necessary for antithrombotic activity. Drug Dev. Res. 51:216–224, 2000. © 2001 Wiley‐Liss, Inc.

References

28